Cell lines | Samples, IC50 values in µg/mL or µM (for Doxorubicin), degrees of resistancea or selectivity indexb (in bracket) | |||
---|---|---|---|---|
Methanol extract | Fractions | Positive control | ||
 | BTL | BTLa | BTLb | Doxorubicin |
CCRF-CEM | 18.13 ± 1.42 | 19.51 ± 0.96 | 17.05 ± 1.03 | 0.02 ± 0.00 |
CEM/ADR5000 Degree of resistancea | 29.20 ± 1.77 (1.61) | 19.16 ± 1.68 (0.98) | 23.49 ± 2.31 (1.37) | 122.96 ± 10.94 (6,683.00) |
MDA-MB-231-pcDNA | 23.09 ± 2.19 | 17.76 ± 2.01 | 24.76 ± 1.93 | 0.13 ± 0.01 |
MDA-MB-231-BCRP Degree of resistance | 26.22 ± 1.61 (1.14) | 20.08 ± 0.89 (1.13) | 64.74 ± 3.82 (2.61) | 0.79 ± 0.08 (6.14) |
HCT116 p53+/+ | 40.84 ± 3.12 | 43.60 ± 2.55 | 52.33 ± 3.71 | 0.48 ± 0.06 |
HCT116 p53−/− Degree of resistance | 28.14 ± 1.83 (0.70) | 47.40 ± 3.28 (1.08) | 48.91 ± 2.89 (0.93) | 1.78 ± 0.08 (3.73) |
U87MG | 22.66 ± 1.76 | 12.46 ± 0.67 | 16.55 ± 1.40 | 0.26 ± 0.03 |
U87MG.ΔEGFR Degree of resistance | 24.43 ± 0.89 (1.07) | 15.61 ± 1.72 (1.25) | 29.05 ± 1.99 (1.21) | 0.98 ± 0.07 (3.79) |
HepG2 | 24.38 ± 1.26 | 18.30 ± 0.77 | 30.65 ± 2.16 | 4.56 ± 0.48 |
AML12 Selectivity indexb | 70.12 ± 3.25 (2.87) |  > 80 (4.37) |  > 80 (2.61) |  > 50 (> 11.59) |